Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–11 of 11 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT07069699
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Double-Expressor Lymphoma, +16 more
- Locations
-
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
- University of Kansas Clinical Research Center Fairway, Kansas, United States
- University of Kansas Cancer Center Kansas City, Kansas, United States
NCT01371630
- Conditions
- B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Burkitt Lymphoma, +23 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT05600686
- Conditions
- Double-Expressor Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, +1 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- UC San Diego Moores Cancer Center San Diego, California, United States
NCT07097363
- Conditions
- B-Cell Non-Hodgkin Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +23 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT04231877
- Conditions
- ALK-Positive Large B-Cell Lymphoma, Aggressive Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, +17 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT05890352
- Conditions
- Grade 3b Follicular Lymphoma, Hemic and Lymphatic Diseases, High Grade B-Cell Lymphoma, +14 more
- Locations
-
- Banner University Medical Center - Tucson Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
- Tower Cancer Research Foundation Beverly Hills, California, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
NCT03742258
- Conditions
- Diffuse Large B-Cell Lymphoma Activated B-Cell Type, Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, +15 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
- Northwestern Lake Forest Hospital Lake Forest, Illinois, United States
Active, Not Recruiting
Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma
NCT04799275
- Conditions
- Ann Arbor Stage III Diffuse Large B-Cell Lymphoma, Ann Arbor Stage IIX (Bulky) Diffuse Large B-Cell Lymphoma, Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma, +30 more
- Locations
-
- Banner University Medical Center - Tucson Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Kaiser Permanente-Anaheim Anaheim, California, United States
Active, Not Recruiting
Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas
NCT03038672
- Conditions
- ALK-Positive Large B-Cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +53 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Moffitt Cancer Center-International Plaza Tampa, Florida, United States
Active, Not Recruiting
Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma
NCT03749018
- Conditions
- Aggressive Non-Hodgkin Lymphoma, Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma, Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma, +22 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Active, Not Recruiting
Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Lymphoma
NCT04323956
- Conditions
- Ann Arbor Stage II Diffuse Large B-Cell Lymphoma, Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage II Marginal Zone Lymphoma, +22 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States